181 related articles for article (PubMed ID: 32620388)
21. Hepatocellular adenoma: what we know, what we do not know, and why it matters.
Bioulac-Sage P; Gouw ASH; Balabaud C; Sempoux C
Histopathology; 2022 May; 80(6):878-897. PubMed ID: 34856012
[TBL] [Abstract][Full Text] [Related]
22. Expression of liver fatty acid binding protein in hepatocellular carcinoma.
Cho SJ; Ferrell LD; Gill RM
Hum Pathol; 2016 Apr; 50():135-9. PubMed ID: 26997447
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of hepatocellular adenoma in men before onset of diabetes in HNF1A-MODY: Watch out for winkers.
Haring MPD; Vriesendorp TM; Klein Wassink-Ruiter JS; de Haas RJ; Gouw ASH; de Meijer VE
Liver Int; 2019 Nov; 39(11):2042-2045. PubMed ID: 31483937
[TBL] [Abstract][Full Text] [Related]
25. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.
Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M
J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic characterization of hepatocellular adenomas in men: a multicenter experience.
González IA; Torbenson M; Sharifai N; Byrnes K; Chatterjee D; Kakar S; Yeh MM; Wu TT; Zhang X; Jain D
Hum Pathol; 2023 Aug; 138():24-33. PubMed ID: 37245629
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular Adenoma in an Infant With Burn-McKeown Syndrome: Report of a Case.
González IA; Surrey LF; Russo P
Pediatr Dev Pathol; 2022; 25(6):668-671. PubMed ID: 36262073
[TBL] [Abstract][Full Text] [Related]
28.
Longerich T; Endris V; Neumann O; Rempel E; Kirchner M; Abadi Z; Uhrig S; Kriegsmann M; Weiss KH; Breuhahn K; Mehrabi A; Weber TF; Wilkens L; Straub BK; Rosenwald A; Schulze F; Brors B; Froehling S; Pellegrino R; Budczies J; Schirmacher P; Stenzinger A
Gut; 2019 Jul; 68(7):1287-1296. PubMed ID: 30901310
[TBL] [Abstract][Full Text] [Related]
29. Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage.
Jeannot E; Mellottee L; Bioulac-Sage P; Balabaud C; Scoazec JY; Tran Van Nhieu J; Bacq Y; Michalak S; Buob D; ; Laurent-Puig P; Rusyn I; Zucman-Rossi J
Diabetes; 2010 Jul; 59(7):1836-44. PubMed ID: 20393147
[TBL] [Abstract][Full Text] [Related]
30. Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-mutated Hepatocellular Adenomas.
Sempoux C; Gouw ASH; Dunet V; Paradis V; Balabaud C; Bioulac-Sage P
Am J Surg Pathol; 2021 Apr; 45(4):477-487. PubMed ID: 33560657
[TBL] [Abstract][Full Text] [Related]
31. Primary hepatocellular adenoma due to biallelic HNF1A mutations and its co-occurrence with MODY 3: case-report and review of the literature.
Fu J; Wang T; Zhai X; Xiao X
Endocrine; 2020 Mar; 67(3):544-551. PubMed ID: 31754975
[TBL] [Abstract][Full Text] [Related]
32. Growth of hepatocellular adenoma during pregnancy: A prospective study.
Gaspersz MP; Klompenhouwer AJ; Broker MEE; Thomeer MGJ; van Aalten SM; Steegers E; Terkivatan T; de Koning H; de Man RA; Ijzermans JNM
J Hepatol; 2020 Jan; 72(1):119-124. PubMed ID: 31550458
[TBL] [Abstract][Full Text] [Related]
33. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for bleeding hepatocellular adenoma in a United States cohort.
McDermott C; Ertreo M; Jha R; Ko J; Fernandez S; Desale S; Fishbein T; Satoskar R; Winslow E; Smith C; Hsu CC
Liver Int; 2022 Jan; 42(1):224-232. PubMed ID: 34687281
[TBL] [Abstract][Full Text] [Related]
36. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
[TBL] [Abstract][Full Text] [Related]
37. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.
Cannella R; Rangaswamy B; Minervini MI; Borhani AA; Tsung A; Furlan A
AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular adenoma: An unsolved diagnostic enigma.
Renzulli M; Clemente A; Tovoli F; Cappabianca S; Bolondi L; Golfieri R
World J Gastroenterol; 2019 May; 25(20):2442-2449. PubMed ID: 31171888
[TBL] [Abstract][Full Text] [Related]
39. New MRI features improve subtype classification of hepatocellular adenoma.
Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
[TBL] [Abstract][Full Text] [Related]
40. Identification of a unique gene expression signature that differentiates hepatocellular adenoma from well-differentiated hepatocellular carcinoma.
Chen ZM; Crone KG; Watson MA; Pfeifer JD; Wang HL
Am J Surg Pathol; 2005 Dec; 29(12):1600-8. PubMed ID: 16327432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
